Phospho-ARHGEF2 (S885) Antibody

What is Phospho-ARHGEF2 (S885) and why is it significant in cellular signaling?

Phospho-ARHGEF2 (S885) refers to the Rho Guanine Nucleotide Exchange Factor 2 (also known as GEF-H1, ARHGEF2, or p40) when specifically phosphorylated at the serine residue at position 885. This phosphorylation site is particularly significant as it represents a key regulatory modification that affects ARHGEF2's function in Rho GTPase signaling pathways. ARHGEF2 plays fundamental roles in numerous cellular processes initiated by extracellular stimuli working through G protein-coupled receptors. The protein forms complexes with G proteins and stimulates Rho-dependent signals, making its phosphorylation state a critical regulatory mechanism for downstream cellular functions .

What are the common applications for Phospho-ARHGEF2 (S885) antibodies?

Phospho-ARHGEF2 (S885) antibodies are versatile tools that can be employed in several experimental techniques:

• Western Blot (WB): Most commonly used at dilutions of 1:500-1:2000 for detecting the phosphorylated form in cell lysates

• Immunohistochemistry (IH): Effective at dilutions of 1:50-1:200 for tissue sections

• ELISA: Can be used at higher dilutions (up to 1:20000) for quantitative detection

• Cell-Based ELISA: Specialized kits allow for in-situ detection of phosphorylated ARHGEF2 in cultured cells

For optimal results, these applications should include appropriate controls to verify specificity, particularly phosphatase-treated samples when working with phospho-specific antibodies.

What species reactivity can be expected with these antibodies?

Most commercial Phospho-ARHGEF2 (S885) antibodies demonstrate cross-reactivity with human, mouse, and rat samples . This cross-reactivity stems from the high conservation of the phosphorylation site and surrounding amino acid sequences across these species. When working with samples from other species, additional validation is recommended as cross-reactivity is not guaranteed despite sequence homology.

How should Western blot protocols be optimized for Phospho-ARHGEF2 (S885) detection?

For optimal Western blot detection of Phospho-ARHGEF2 (S885), implement the following methodological considerations:

• Protein Loading: Use 25-30μg of total protein per lane for cell lysates

• Expected Band Size: Look for bands at approximately 110-120kDa (observed molecular weight, with calculated MW of 111-112kDa)

• Blocking Conditions: 3% BSA in TBST is recommended over milk-based blockers (milk contains phospho-proteins that may increase background)

• Antibody Dilution: Start with 1:1000 dilution in blocking buffer and adjust as needed

• Secondary Antibody: HRP-conjugated anti-rabbit IgG at 1:10000 dilution is typical

• Detection System: ECL-based detection systems provide sufficient sensitivity

• Phosphatase Controls: Include lysates treated with calf intestinal phosphatase (CIP) as negative controls (20μl CIP per 400μl lysate, incubated at 37°C for 1 hour)

• Phosphatase Inhibitors: Always include phosphatase inhibitors in lysis buffers to preserve phosphorylation status

These conditions have been validated in various cell lines including HEK293T, Myla2059, and C6 cells .

What are the critical considerations for immunohistochemical detection?

For successful immunohistochemical detection of Phospho-ARHGEF2 (S885) in tissue sections, follow these methodological steps:

• Tissue Preparation: Use formalin-fixed paraffin-embedded (FFPE) sections

• Antigen Retrieval: Heat-mediated antigen retrieval with sodium citrate buffer (pH 6.0) is essential

• Antibody Dilution: Begin with 1:100 dilution and optimize as needed

• Incubation Conditions: Overnight incubation at 4°C tends to yield best results

• Detection System: HRP-conjugated compact polymer systems with DAB as chromogen

• Counterstaining: Haematoxylin counterstaining followed by DPX mounting

• Controls: Include peptide competition controls using the immunizing phosphopeptide to confirm specificity

This protocol has been successfully applied to human brain tissue sections, demonstrating specific neuronal staining patterns .

How can I validate the specificity of Phospho-ARHGEF2 (S885) antibodies?

Rigorous validation of phospho-specific antibodies is critical for reliable research outcomes. Implement these methodological approaches:

• Phosphatase Treatment Control:

  • Treat half of your sample with calf intestinal phosphatase (CIP)

  • Compare treated and untreated samples by Western blot

  • The specific signal should disappear or significantly decrease in phosphatase-treated samples

• Peptide Competition Assay:

  • Pre-incubate the antibody with excess immunizing phosphopeptide

  • Run parallel experiments with blocked and unblocked antibody

  • Specific signals should be absent in the peptide-competed conditions

• Specificity Against Non-phosphorylated Protein:

  • Compare detection using phospho-specific and total ARHGEF2 antibodies

  • The phospho-specific antibody should not detect recombinant non-phosphorylated ARHGEF2

• Phospho-mimetic and Phospho-deficient Mutants:

  • Express S885A (phospho-deficient) and S885E (phospho-mimetic) mutants

  • Verify differential detection that correlates with phosphorylation status

What signaling pathways regulate ARHGEF2 S885 phosphorylation?

ARHGEF2 phosphorylation at S885 is regulated by several signaling pathways that should be considered when designing experiments:

• PKA Pathway: Cyclic AMP-dependent protein kinase A has been implicated in ARHGEF2 phosphorylation, suggesting integration with G-protein coupled receptor signaling

• Cell Cycle Regulation: Phosphorylation states change throughout the cell cycle, particularly during mitosis

• Mechanical Stress Signaling: ARHGEF2/GEF-H1 responds to mechanical cues partly through phosphorylation events

When studying these pathways, consider experimental designs that:

• Manipulate specific kinase activities using selective inhibitors

• Employ cell synchronization techniques to capture cell cycle-dependent effects

• Include conditions that alter the mechanical environment (substrate stiffness, stretch)

How does ARHGEF2 S885 phosphorylation affect its localization and function?

The functional significance of S885 phosphorylation includes several regulatory aspects:

• Microtubule Binding: Phosphorylation at S885 may alter ARHGEF2's association with microtubules, affecting its subcellular localization

• GEF Activity Regulation: Phosphorylation can modulate the guanine nucleotide exchange factor activity toward Rho GTPases

• Protein Interactions: Modified phosphorylation status may create or disrupt protein-protein interaction sites

Methodological approaches to investigate these effects include:

• Subcellular fractionation to assess distribution between cytoskeletal and cytosolic fractions

• In vitro GEF activity assays comparing wild-type and phospho-mimetic variants

• Co-immunoprecipitation studies to identify phosphorylation-dependent interactors

What are common troubleshooting issues when working with Phospho-ARHGEF2 (S885) antibodies?

How should Phospho-ARHGEF2 (S885) antibodies be stored and handled?

For optimal antibody performance and longevity, follow these storage and handling guidelines:

• Storage Temperature: Store at -20°C in manufacturer-provided buffer

• Buffer Composition: Typically contains 30-50% glycerol, phosphate buffers (pH 7.3-7.4), and 0.01-0.02% sodium azide

• Aliquoting: Upon receipt, prepare small working aliquots to avoid repeated freeze-thaw cycles

• Thawing Protocol: Thaw slowly on ice or at 4°C rather than at room temperature

• Working Dilutions: Prepare fresh working dilutions on the day of experiment

• Shelf Life: Most antibodies remain stable for at least one year when properly stored

How can Phospho-ARHGEF2 (S885) analysis be integrated into broader signaling studies?

Advancing research with Phospho-ARHGEF2 (S885) antibodies can be enhanced through integration with complementary methodologies:

• Multiplexed Phospho-Protein Analysis:

  • Combine with other phospho-antibodies targeting related signaling molecules

  • Implement multiplexed Western blotting or flow cytometry

  • Consider phospho-proteomics approaches for comprehensive pathway analysis

• Live-Cell Imaging:

  • Develop phospho-sensitive biosensors based on conformational changes

  • Employ FRET-based approaches to monitor phosphorylation dynamics

  • Correlate phosphorylation with subcellular localization in real-time

• Single-Cell Analysis:

  • Apply cell-based ELISA in heterogeneous populations

  • Combine with single-cell RNA-seq for correlation with transcriptional outputs

  • Consider mass cytometry (CyTOF) with metal-conjugated phospho-antibodies

These approaches allow researchers to place ARHGEF2 phosphorylation in the broader context of cellular signaling networks and may reveal novel regulatory mechanisms.

What are the normalization strategies for Phospho-ARHGEF2 detection in cell-based assays?

When quantifying Phospho-ARHGEF2 (S885) levels, especially in cell-based ELISA formats, multiple normalization approaches should be considered:

• Total Protein Normalization:

  • Use anti-ARHGEF2 antibodies (non-phospho-specific) in parallel wells

  • Calculate the ratio of phosphorylated to total protein

  • This controls for variations in total ARHGEF2 expression levels

• Housekeeping Protein Control:

  • Utilize anti-GAPDH antibodies as internal positive controls

  • Normalize phospho-signal to GAPDH signal

  • This approach controls for well-to-well variations in cell number

• Cell Number Normalization:

  • Implement Crystal Violet whole-cell staining after the primary assay

  • Normalize phospho-signal to cell density measurements

  • This methodology adjusts for differences in plating density

These normalization strategies are essential for obtaining reliable, quantitative data, particularly when comparing different experimental conditions or treatments.